These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22427614)

  • 1. Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis.
    Salas V; Pastor FJ; Calvo E; Sutton DA; Chander J; Mayayo E; Alvarez E; Guarro J
    J Antimicrob Chemother; 2012 Jul; 67(7):1712-5. PubMed ID: 22427614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
    Salas V; Pastor FJ; Calvo E; Sutton D; García-Hermoso D; Mayayo E; Dromer F; Fothergill A; Alvarez E; Guarro J
    Med Mycol; 2012 Oct; 50(7):710-5. PubMed ID: 22458251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
    Salas V; Pastor FJ; Calvo E; Alvarez E; Sutton DA; Mayayo E; Fothergill AW; Rinaldi MG; Guarro J
    Antimicrob Agents Chemother; 2012 May; 56(5):2246-50. PubMed ID: 22290952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
    Rodríguez MM; Pastor FJ; Serena C; Guarro J
    J Antimicrob Chemother; 2009 Feb; 63(2):361-4. PubMed ID: 19054804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species.
    Calvo E; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2010 Jul; 65(7):1455-9. PubMed ID: 20488983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
    Spreghini E; Orlando F; Giannini D; Barchiesi F
    J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae.
    Rodríguez MM; Serena C; Mariné M; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3786-8. PubMed ID: 18694953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posaconazole for the treatment of mucormycosis.
    Enoch DA; Aliyu SH; Sule O; Lewis SJ; Karas JA
    Int J Antimicrob Agents; 2011 Dec; 38(6):465-73. PubMed ID: 21782392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales).
    Chander J; Stchigel AM; Alastruey-Izquierdo A; Jayant M; Bala K; Rani H; Handa U; Punia RS; Dalal U; Attri AK; Monzon A; Cano-Lira JF; Guarro J
    Rev Iberoam Micol; 2015; 32(2):93-8. PubMed ID: 25576377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats.
    Ullmann AJ; Krammes E; Sommer S; Buschmann I; Jahn-Muehl B; Cacciapuoti A; Schmitt HJ
    J Antimicrob Chemother; 2007 Nov; 60(5):1080-4. PubMed ID: 17855727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.
    Perkhofer S; Locher M; Cuenca-Estrella M; Rüchel R; Würzner R; Dierich MP; Lass-Flörl C
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2636-8. PubMed ID: 18458135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apophysomyces variabilis as an emerging pathogen in Mainland China.
    Li XY; Wang SJ; Huang GM; Zheng DY; Al-Odaini N; Pan KS; Zheng YQ; Cao CW
    Mycoses; 2023 Sep; 66(9):795-800. PubMed ID: 37226871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.
    Luo G; Gebremariam T; Lee H; French SW; Wiederhold NP; Patterson TF; Filler SG; Ibrahim AS
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3340-7. PubMed ID: 23650163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posaconazole prophylaxis in experimental systemic zygomycosis.
    Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Pisa E; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2007 Jan; 51(1):73-7. PubMed ID: 17060525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.
    Espinel-Ingroff A; Chakrabarti A; Chowdhary A; Cordoba S; Dannaoui E; Dufresne P; Fothergill A; Ghannoum M; Gonzalez GM; Guarro J; Kidd S; Lass-Flörl C; Meis JF; Pelaez T; Tortorano AM; Turnidge J
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1745-50. PubMed ID: 25583714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report of hepatic mucormycosis after liver transplantation: successful treatment with liposomal amphotericin B followed by posaconazole sequential therapy.
    Abboud CS; Bergamasco MD; Baía CE; Lallée MP; Zan AS; Zamorano MM; Pereira OI; Mies S
    Transplant Proc; 2012 Oct; 44(8):2501-2. PubMed ID: 23026630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
    Chowdhary A; Singh PK; Kathuria S; Hagen F; Meis JF
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7882-7. PubMed ID: 26438489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The environmental source of emerging Apophysomyces variabilis infection in India.
    Prakash H; Ghosh AK; Rudramurthy SM; Paul RA; Gupta S; Negi V; Chakrabarti A
    Med Mycol; 2016 Aug; 54(6):567-75. PubMed ID: 27118802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
    Treviño-Rangel Rde J; López LJ; Palma-Nicolás JP; Hernández-Bello R; González JG; González GM
    J Antimicrob Chemother; 2014 Apr; 69(4):1075-8. PubMed ID: 24252752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.